Fundraising Fox

Brent Ahrens

InvestorFounder

General Partner at Canaan Partners · Board director at Transposon Therapeutics · Board director at Unchained Labs · Board director at Minimally Invasive Devices

Menlo Park, California

Writes $250K – $20M checks · typically $10M

FoundedEndoGastric SolutionsMinimally Invasive DevicesRelievant MedsystemsTransposon TherapeuticsUnchained Labs

About

Brent Ahrens, a longtime West Coast healthcare lead since 1999, uniquely combines deep biopharma and medtech investing with a Kauffman Fellows background and active mentorship of new VCs.

Invests in

BiotechConsumerDeep TechEnterprise SoftwareFintechHardwareHealthtechMedical Devices

Board director at Transposon Therapeutics

Intro paths

In turn, Brent can intro founders to Transposon Therapeutics's investors below.

Co-founders at Transposon Therapeutics

DP
Dennis PodlesakExecutive Officer, Director
LRLynne R. Rollins
Lynne R. RollinsExecutive Officer
EW
Eckard Weber, MDExecutive Officer, Director
EW
Eckard Weber, M.D.Executive Officer, Director

Board director at Unchained Labs

Intro paths

In turn, Brent can intro founders to Unchained Labs's investors below.

Co-founders at Unchained Labs

TH
Tim HarknessExecutive Officer, Director
JN
Jason NoviExecutive Officer

Board director at Minimally Invasive Devices

Intro paths

In turn, Brent can intro founders to Minimally Invasive Devices's investors below.

Minimally Invasive Devices's investors · 1

Co-founders at Minimally Invasive Devices

WP
Wayne PollExecutive Officer, Director
RA
Renee AlbaranoExecutive Officer
CC
Caroline CrisafulliExecutive Officer

Experience

  1. Canaan PartnersGeneral Partnercurrent2005 — presentSan Francisco Bay Area
  2. Canaan PartnersPrincipal1999 — 2004Menlo Park/SF
  3. GSIDirector Business Development and Marketing1997 — 1999Cupertino, CA
  4. Johnson & JohnsonEngineer1991 — 1995Cincinnati Metropolitan Area
  5. IAP ResearchEngineer1986 — 1991Dayton Metropolitan Area

Education

  1. The Tuck School of Business at DartmouthMaster of Business Administration - MBA, Finance1995 — 1997
  2. University of DaytonMaster's degree, Mechanical Engineering1985 — 1986
  3. University of DaytonBachelor's degree, Mechanical Engineering1981 — 1985

Deals · 5

Transposon TherapeuticsBoard seat

via Canaan Partners · filed Dec 2020 · $45.2M raise

Minimally Invasive DevicesBoard seat

via Canaan Partners · filed Nov 2015 · $14.1M raise

Unchained LabsBoard seat

via Canaan Partners · filed Jun 2015 · $31M raise

EndoGastric SolutionsBoard seat

via Canaan Partners · filed Apr 2015 · $1.5M raise

Relievant MedsystemsBoard seat

via Canaan Partners · filed Feb 2015 · $5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Canaan Partners

Network4

Investors connected to Brent in public investor directories — a warm-intro map.

Frequently asked questions

Where does Brent Ahrens work?
Brent Ahrens is General Partner at Canaan Partners and Founder at Transposon Therapeutics and Founder at Unchained Labs and Founder at Minimally Invasive Devices.
What does Brent Ahrens invest in?
Brent Ahrens invests in Biotech, Consumer, Deep Tech, Enterprise Software, Fintech, Hardware, Healthtech, Medical Devices.
What check size does Brent Ahrens write?
Brent Ahrens typically writes checks of $250K – $20M.
What companies did Brent Ahrens found?
Brent Ahrens founded EndoGastric Solutions, Minimally Invasive Devices, Relievant Medsystems, Transposon Therapeutics, Unchained Labs.

Same school

Shared employers